Trials / Completed
CompletedNCT06742840
A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-2129 Following Multiple Doses Administration in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-2129 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-2129 | HRS-2129. |
| DRUG | HRS-2129 placebo | HRS-2129 placebo. |
Timeline
- Start date
- 2024-12-30
- Primary completion
- 2025-07-02
- Completion
- 2025-07-02
- First posted
- 2024-12-19
- Last updated
- 2025-09-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06742840. Inclusion in this directory is not an endorsement.